Clinical Trial Update: Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dapagliflozin as add-on therapy for glycemic status and quality of life in type 2 diabetes with diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mohammed Mahmood Mohammed | Conditions: Diabetic Nephropathy Type 2 | Phase 4 | Status: COMPLETED